透壁程度与位置对13N-氨正电子发射断层显像检测心肌纤维化诊断效能的影响:一项正电子发射断层/磁共振混合研究
100例疑似或已知冠心病(n=50)或心肌炎病史(n=50)患者在同机PET/MR上同期行心脏磁共振(CMR)和13N-氨PET显像,以晚期钆增强定义左心室心肌纤维化。定性分析PET检测纤维化的敏感度和特异度在患者水平为83.6%和84.9%,在节段水平为52.9%和96.4%,优于基于阈值的半定量和定量分析。节段水平敏感度随透壁程度增加而升高,且心内膜下纤维化敏感度高于心外膜下和壁中层(P < .001);PET所示总体纤维化范围中位数显著小于CMR(2.0 [IQR 1.0-5.0] vs 3.0 [IQR 2.0-6.0] 个节段,P < .001)。
要点
- 患者水平定性PET检测纤维化敏感度83.6%、特异度84.9%,优于基于阈值的半定量和定量分析。
- 节段水平定性PET敏感度52.9%、特异度96.4%,敏感度随透壁程度增加而升高。
- 节段水平敏感度心内膜下高于心外膜下和壁中层(P < .001),PET总体纤维化范围中位数小于CMR。
核心结论
- 患者水平上,PET检测缺血性或炎症性病因的左心室心肌纤维化具有高敏感度。
- 与CMR相比,PET总体纤维化范围被显著低估,因节段水平上低透壁程度及心外膜下和壁中层纤维化的敏感度显著低于心内膜下纤维化。
研究设计与样本
- 共纳入100例患者,其中疑似或已知冠心病50例、心肌炎病史50例。
- 所有患者在同机PET/MR设备上同期行心脏磁共振(CMR)和13N-氨PET显像。
- 以CMR晚期钆增强定义左心室心肌纤维化为参考,记录每个节段的透壁程度和位置(心内膜下、壁中层或心外膜下)。
- PET心肌灌注显像分别进行定性(视觉)、半定量和定量(均为基于阈值)分析。
主要发现
- 定性分析PET检测纤维化的敏感度和特异度在患者水平为83.6%和84.9%,在节段水平为52.9%和96.4%。
- 定性分析PET优于基于阈值的半定量和定量分析。
- 节段水平上,PET敏感度随透壁程度增加而升高,并取决于位置,心内膜下纤维化敏感度高于心外膜下或壁中层纤维化(P < .001)。
- PET所示总体纤维化范围中位数显著小于CMR(2.0 [IQR 1.0-5.0] vs 3.0 [IQR 2.0-6.0] 个节段,P < .001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The influence of fibrosis transmurality and location on the diagnostic performance of positron emission tomography (PET) myocardial perfusion imaging (MPI) for detecting myocardial fibrosis remains unclear. METHODS AND RESULTS: One hundred patients with suspected or known coronary artery disease (n = 50) or with a history of myocarditis (n = 50) underwent simultaneous cardiac magnetic resonance (CMR) and 13N-ammonia PET imaging on a hybrid positron emission tomography/magnetic resonance (PET/MR) device. CMR served as the reference with late gadolinium enhancement defining fibrosis of the left ventricular myocardium. PET MPI was assessed for fibrosis qualitatively (i.e. visually), semiquantitatively, and quantitatively (both threshold-based). From CMR, for every segment, the transmurality and location (subendocardial, midmyocardial, or subepicardial) of fibrosis were recorded. The sensitivity and specificity of qualitatively analyzed PET to detect fibrosis were 83.6% and 84.9% per patient and 52.9% and 96.4% per segment, respectively, outperforming the threshold-based semiquantitative and quantitative analyses. On a per-segment basis, the sensitivity of PET was increasing with transmurality and was dependent on location with higher sensitivities for subendocardial than subepicardial or midmyocardial fibrosis (P < .001). Overall median fibrosis extent, as depicted by PET, was significantly smaller than by CMR (2.0 [IQR 1.0-5.0] vs 3.0 [IQR 2.0-6.0] segments, P < .001). CONCLUSIONS: PET yields high sensitivity for the detection of left ventricular (LV) myocardial fibrosis of ischemic or inflammatory etiology on a per-patient basis. However, compared to CMR, the overall fibrosis extent is significantly underestimated because, on a segmental level, sensitivities are significantly lower for fibrosis with lower transmurality and those located subepicardial and midmyocardial, as compared to subendocardial.
引用
- Heiniger PS, Igual GD, Galafton A, et al. Impact of transmurality and location on the diagnostic performance of 13N-ammonia positron emission tomography in the detection of myocardial fibrosis - A hybrid positron emission tomography/magnetic resonance study. J Nucl Cardiol. 2025. PMID: 40032238. doi:10.1016/j.nuclcard.2025.102172
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。